ethinyl estradiol has been researched along with naloxone in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (40.00) | 29.6817 |
| 2010's | 4 (26.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Strassburg, CP; Tukey, RH | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Chang, TK; Ensom, MH; Kiang, TK | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Carranza-Lira, S; Garza-Flores, J; Gonzalez-Castillo, A; Mendez, JP; Peres-Palacios, G; Ulloa-Aguirre, A | 1 |
| Dawood, MY; Khan-Dawood, FS; Snowden, EU | 1 |
| Gooren, LJ; Sassen, AM; van Bergeijk, L; van Kessel, H | 1 |
| Cagnacci, A; Fioretti, P; Gambacciani, M; Gargiulo, T; Melis, GB; Pallotti, A; Paoletti, AM; Petacchi, FD | 1 |
| Jelinek, J; Kappen, A; Lomax, P; Schönbaum, E | 1 |
| Alfinito, PD; Atherton, J; Chen, X; Cosmi, S; Deecher, DC | 1 |
2 review(s) available for ethinyl estradiol and naloxone
| Article | Year |
|---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
UDP-glucuronosyltransferases and clinical drug-drug interactions.
Topics: Clinical Trials as Topic; Drug Interactions; Enzyme Activation; Enzyme Induction; Glucuronides; Glucuronosyltransferase; Humans; Pharmaceutical Preparations; Pharmacogenetics; Polymorphism, Genetic | 2005 |
13 other study(ies) available for ethinyl estradiol and naloxone
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Changes in the responsiveness of luteinizing hormone secretion to infusion of the opioid antagonist naloxone throughout male sexual maturation.
Topics: Adolescent; Child; Ethinyl Estradiol; Humans; Luteinizing Hormone; Male; Naloxone; Pituitary Gland; Pituitary Hormone-Releasing Hormones; Sexual Maturation; Testosterone | 1988 |
Opioid regulation of pituitary gonadotropins and prolactin in women using oral contraceptives.
Topics: Adult; Contraceptives, Oral, Hormonal; Endorphins; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Follicle Stimulating Hormone; Humans; Hypothalamo-Hypophyseal System; Luteinizing Hormone; Menstrual Cycle; Naloxone; Norgestrel; Prolactin; Radioimmunoassay; Time Factors | 1986 |
Effects of naloxone infusion on plasma levels of LH, FSH, and in addition TSH and prolactin in males, before and after oestrogen or anti-oestrogen treatment.
Topics: Adult; Estradiol; Ethinyl Estradiol; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Male; Naloxone; Oligospermia; Prolactin; Tamoxifen; Testosterone; Thyrotropin; Transsexualism | 1986 |
Disappearance of opioid control of LH secretion in short term ovariectomized women.
Topics: Adult; Castration; Ethinyl Estradiol; Female; Genital Diseases, Female; Humans; Hysterectomy; Kinetics; Luteinizing Hormone; Naloxone | 1985 |
A primate model of human postmenopausal hot flushes.
Topics: Anabolic Agents; Animals; Body Temperature Regulation; Castration; Climacteric; Clonidine; Ethinyl Estradiol; Female; Macaca; Models, Biological; Naloxone; Norpregnenes; Skin Temperature | 1984 |
ICI 182,780 penetrates brain and hypothalamic tissue and has functional effects in the brain after systemic dosing.
Topics: Animals; Blood-Brain Barrier; Body Weight; Disease Models, Animal; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Ethinyl Estradiol; Female; Fulvestrant; Hot Flashes; Hypothalamus; Morphine; Naloxone; Narcotic Antagonists; Narcotics; Ovariectomy; Rats; Rats, Sprague-Dawley; Skin Temperature; Uterus | 2008 |